摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cis-5-benzylhexahydro-1H-furo[3,4-c]pyrrole | 55129-06-1

中文名称
——
中文别名
——
英文名称
cis-5-benzylhexahydro-1H-furo[3,4-c]pyrrole
英文别名
(3aR,6aS)-5-Benzylhexahydro-1H-furo[3,4-c]pyrrole;(3aR,6aS)-5-benzyl-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]pyrrole
cis-5-benzylhexahydro-1H-furo[3,4-c]pyrrole化学式
CAS
55129-06-1
化学式
C13H17NO
mdl
——
分子量
203.284
InChiKey
CVRHDLHYOBFXGB-BETUJISGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    295.9±33.0 °C(Predicted)
  • 密度:
    1.108±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    12.5
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:c63be43cf0c71df039b5b2fb5e495ad5
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    cis-5-benzylhexahydro-1H-furo[3,4-c]pyrrole盐酸 作用下, 以 四氢呋喃1,4-二氧六环 为溶剂, 生成 cis-5-benzylhexahydro-1H-furo[3,4-c]pyrrole hydrochloride
    参考文献:
    名称:
    3-Oxa-7-氮杂双环[3.3.0]辛烷的一种方法—双环吗啉代用品
    摘要:
    摘要 报道了一种3-氧杂-7-氮杂双环[3.3.0]辛烷,双环吗啉类似物的方法,该方法依赖于[3 + 2]马来酸酐或呋喃-2(5 H)-环和原位环加成。生成甲亚胺叶立德。该方法的实用性在多克尺度上得到了证明。 报道了一种3-氧杂-7-氮杂双环[3.3.0]辛烷,双环吗啉类似物的方法,该方法依赖于[3 + 2]马来酸酐或呋喃-2(5 H)-环和原位环加成。生成甲亚胺叶立德。该方法的实用性在多克尺度上得到了证明。
    DOI:
    10.1055/s-0036-1588785
  • 作为产物:
    描述:
    顺式-(1-苄基吡咯烷-3,4-二基)二甲醇potassium tert-butylate甲基磺酰氯 作用下, 以 四氢呋喃 为溶剂, 反应 3.25h, 以56%的产率得到cis-5-benzylhexahydro-1H-furo[3,4-c]pyrrole
    参考文献:
    名称:
    3-Oxa-7-氮杂双环[3.3.0]辛烷的一种方法—双环吗啉代用品
    摘要:
    摘要 报道了一种3-氧杂-7-氮杂双环[3.3.0]辛烷,双环吗啉类似物的方法,该方法依赖于[3 + 2]马来酸酐或呋喃-2(5 H)-环和原位环加成。生成甲亚胺叶立德。该方法的实用性在多克尺度上得到了证明。 报道了一种3-氧杂-7-氮杂双环[3.3.0]辛烷,双环吗啉类似物的方法,该方法依赖于[3 + 2]马来酸酐或呋喃-2(5 H)-环和原位环加成。生成甲亚胺叶立德。该方法的实用性在多克尺度上得到了证明。
    DOI:
    10.1055/s-0036-1588785
点击查看最新优质反应信息

文献信息

  • FUMAGILLOL SPIROCYCLIC COMPOUNDS AND FUSED BICYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME
    申请人:Zafgen, Inc.
    公开号:US20180079737A1
    公开(公告)日:2018-03-22
    Disclosed herein, in part, are fumagillol compounds and methods of use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making fumagillol compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.
  • US9944613B2
    申请人:——
    公开号:US9944613B2
    公开(公告)日:2018-04-17
  • [EN] FUMAGILLOL SPIROCYCLIC COMPOUNDS AND FUSED BICYCLIC COMPOUNDS AND THEIR USE AS METAP2 INHIBITORS<br/>[FR] COMPOSÉS SPIROCYCLIQUES DE TYPE FUMAGILLOL ET COMPOSÉS BICYCLIQUES CONDENSÉS ET LEUR UTILISATION COMME INHIBITEURS DE LA MÉTAP2
    申请人:ZAFGEN INC
    公开号:WO2017027687A1
    公开(公告)日:2017-02-16
    Disclosed herein are fumagillol compounds of Formula (I) or Formula (Ia): wherein: Y is a bond or NR8; X is N or CRN; wherein X is N when Y is a bond and X is CRN when Y is NR8; n is 0 or 1; m is 1 or 2; Ring A may be optionally substituted by one or two substituents as defined; and R1 and R2, together with the carbon or carbons to which they are attached, form a 4-6 membered saturated heterocyclic ring B having one or two heteroatoms selected from the group consisting of O, S(O)w (wherein w is 0, 1 or 2) and NRh or form a 3-6 membered saturated carbocyclic ring B; wherein the heterocyclic or carbocyclic ring B may optionally be substituted as defined; and methods of use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making fumagillol compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.
  • An Approach to 3-Oxa-7-azabicyclo[3.3.0]octanes – Bicyclic Morpholine Surrogates
    作者:Oleksandr Grygorenko、Yevhenii Sokolenko、Eugeniy Ostapchuk、Artem Artemenko
    DOI:10.1055/s-0036-1588785
    日期:2017.7
    bicyclic morpholine analogues, is reported, which relies on [3+2] cycloaddition of maleic anhydrides or furan-2(5H)-ones and an in situ generated azomethine ylide. The utility of the method was demonstrated on a multigram scale. An approach to 3-oxa-7-azabicyclo[3.3.0]octanes, bicyclic morpholine analogues, is reported, which relies on [3+2] cycloaddition of maleic anhydrides or furan-2(5H)-ones and an in
    摘要 报道了一种3-氧杂-7-氮杂双环[3.3.0]辛烷,双环吗啉类似物的方法,该方法依赖于[3 + 2]马来酸酐或呋喃-2(5 H)-环和原位环加成。生成甲亚胺叶立德。该方法的实用性在多克尺度上得到了证明。 报道了一种3-氧杂-7-氮杂双环[3.3.0]辛烷,双环吗啉类似物的方法,该方法依赖于[3 + 2]马来酸酐或呋喃-2(5 H)-环和原位环加成。生成甲亚胺叶立德。该方法的实用性在多克尺度上得到了证明。
查看更多

同类化合物

顺式-六氢呋喃并[3,4-C]吡咯 甲基4-甲基-4H-呋喃并[3,2-b]吡咯-5-羧酸酯 氮杂环丁烷并[1,2-a]呋喃并[2,3-c]吡咯 夫沙瑞汀A 呋喃并吡咯甲酸 六氢-1H-呋喃并[3,4-c]吡咯 六氢-1H-呋喃并[3,4-C]吡咯 八氢-呋喃并[3,2-c]吡啶 乙基4,6-二氢-5H-呋喃并[2,3-c]吡咯-5-羧酸酯 6H-呋喃并[2,3-b]吡咯-5-羧酸甲酯 6-甲基-6H-呋喃并[2,3-b]吡咯-5-羧酸 6-甲基-6H-呋喃并[2,3-b]吡咯-5-甲酰肼 4H-呋喃并[3,2-b]吡咯-5-羧酸乙酯 4H-呋喃并[3,2-b]吡咯-5-羧酸,2-甲酰基-,甲基酯 4H-呋喃并[3,2-b]吡咯 4H-呋喃并[3,2-B!吡咯-5-羧酸甲酯 4-甲基呋喃[3,2-b]吡咯-5-羧酸乙酯 4-甲基-4H-呋喃并[3,2-b]吡咯 4-甲基-4H-呋喃并[3,2-B]吡咯-5-甲酸 365-苄基六氢-1H-呋喃[34-c]吡咯 3-溴-4H-呋喃并[3,2-b]吡咯-5-羧酸 3-溴-4H-呋喃并[3,2-b]吡咯-5-甲酸乙酯 2-苯基-4H-呋喃并[3,2-b]吡咯-5-羧酸 2-甲酰基-6-甲基-6H-呋喃并[2,3-b]吡咯-5-羧酸 2-甲酰基-4-甲基-4H-呋喃并[3,2-b]吡咯-5-羧酸甲酯 2-甲基-4H-呋喃并[3,2-b]吡咯-5-羧酸甲酯 2-甲基-4H-呋喃并[3,2-b]吡咯-5-羧酸乙酯 2-甲基-4H-呋喃并[3,2-b]吡咯-5-羧酸 2-溴-4H-呋喃并[3,2-b]吡咯-5-羧酸乙酯 2-溴-4H-呋喃并[3,2-B]吡咯-5-羧酸 2-(4-甲氧基苯基)-4H-呋喃并[3,2-b]吡咯-5-羧酸乙酯 2-(4-甲氧基苯基)-4H-呋喃并[3,2-b]吡咯-5-羧酸 2,3,3A,4-四氢-5H-呋喃并[3,2-b]吡咯-5-酮 1-(4H-呋喃并[3,2-b]吡咯-4-基)乙酮 1-(2-甲基-4H-呋喃并[3,2-b]吡咯-4-基)乙酮 (9ci)-1-甲基-1H-呋喃并[3,4-b]吡咯-4,6-二酮 (4-甲基-4H-呋喃并[3,2-b]吡咯-5-基)甲醇 (3aR,6aR)-4-乙酰基六氢-2H-呋喃并[3,2-b]吡咯-2-酮 5-(3-chloropropyl)hexahydro-1H-furo[3,4-c]pyrrole Methyl 2-[2-cyano-2-(methoxycarbonyl)vinyl]-6-methoxyfuro[2,3-b]pyrrole-5-carboxylate Methyl 6-methoxymethyl-2-(3,3,6,6-tetramethyl-1(2H),8(7H)-dioxo-3,4,5,6-tetrahydro-9H-xanthen-9-yl)furo[2,3-b]pyrrole-5-carboxylate methyl 2-cyano-6-(methoxymethyl)furo[2,3-b]pyrrole-5-carboxylate Methyl 2-(2,2-dicyanovinyl)-6-methoxymethylfuro[2,3-b]pyrrole-5-carboxylate (1R,5S,1'S)-1,5-dimethyl-8-phenylethyl-2-oxa-8-azabicyclo[3.3.0]octane-3,7-dione (1S,5R,1'S)-1,5-dimethyl-8-phenylethyl-2-oxa-8-azabicyclo[3.3.0]octane-3,7-dione {3-[2-(4-chloro-phenyl)-6-oxo-4-thioxo-6H-1-oxa-3b,5-diaza-cyclopenta[a]pentalen-5-yl]-propyl}-phosphonic acid diethyl ester methyl 4-(3,4-dichlorobenzyl)-2-formylfuro[3,2-b]pyrrole-carboxylate (3aR,6aS)-5-benzyl-3a,6a-dimethyltetrahydro-1H-furo[3,4-c]pyrrole-1,3(3aH)-dione (1R,2R,6R,8R,15S)-10,14-aza-4,4-dimethyl-11-oxo-1-mesyloxy-3,5,7-trioxa-tetracyclo[7.6.0.02,6.010,15]pentadecane 5-methyl-1,3-bis(3-oxobutyl)dihydro-1H-furo[3,4-c]pyrrole-4,6(5H,6aH)-dione